Classification and surgical treatment of congential biliary dilatation
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 2
Abstract
Congential biliary dilitation (CBD) is rare biliary tract disease in clinic. Clinical classification and disease characteristics of CBD is the key of accurate treatment. Surgical treatment was regarded as the first choice for adult patients with CBD including traditional surgery. There is still a controversy in the strategy of reconstruction of bile duct during operation. In this article the progress in diagnosis and treatment of CBD was reviewed.
Authors and Affiliations
Jin WANG, Shuodong WU
Keywords
Related Articles
- EP ID EP750863
- DOI 10.16139/j.1007-9610.2023.02.15
- Views 17
- Downloads 0
Current status and prospect of CAR-T cell immunotherapy for colorectal cancer
Chimeric antigen receptor T (CAR-T) cell therapy is a new method of immunotherapy for cancer that has achieved remarkable results in treating blood tumors. However, colorectal cancer(CRC), as a solid tumor, has different...
Practice of single-port and reduced-port laparoscopic gastric cancer surgery in China
The application and development of laparoscopic surgery for gastric cancer has experienced a history of more than two decades, from exploratory development to clinical validation, and then to large-scale clinical studies...
Vascular reconstruction in radical resection for hilar cholangiocarcinoma
Radical resection is the only option of curative treatment for hilar cholangiocarcinoma. Microscopically negative resection margin of bile duct (R0 resection) is critical for long-term survival of patients. However, both...
The strategy of extrahepatic organs management in early period after adult liver transplantation
With the improvements in surgical technique, the indications for liver transplantation(LT) are being expanded to more complex and severe patients, who not only have liver function in the terminal stage, but also extrahep...
Emerging developments in immune checkpoint inhibitor therapy for gastroenteropancreatic neuroendocrine neoplasm
Immunotherapies targeting immune checkpoints have undergone rapid evolution, and have been preliminary explored in treatment of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) in recent years. However, their pot...